Exact Sciences Company

Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
Technology:
Сancer Diagnostics
Industry:
Omic
Headquarters:
Madison, Wisconsin, United States
Founded Date:
1995-01-01
Employees Number:
501-1000
Funding Status:
IPO
Acquisitions Number:
12
Investors Number:
1
Total Funding:
$1,032,200,000.00
Estimated Revenue:
$100M to $500M
Last Funding Date:
2020-02-24
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership